(Total Views: 500)
Posted On: 08/28/2025 8:33:41 AM
Post# of 158145
https://www.cytodyn.com/newsroom/press-releas...7th-annual
So they're in sales mode? Oh boy.
/s
So they're in sales mode? Oh boy.
/s
Quote:
VANCOUVER, Washington, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company", a clinical-stage biotechnology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, today announced that management will participate in the H.C. Wainwright 27th Annual Global Investment Conference being held September 8 to 10, 2025, at the Lotte New York Palace Hotel in New York City.
Robert E. Hoffman, Chief Financial Officer, will deliver a presentation on Wednesday, September 10, at 1:30 p.m. EDT, which will be accessible via webcast here, and will be available for one-on-one meetings with registered conference attendees.
(10)
(0)
